What is the recommended dosage frequency for cosentyx?

How often do patients typically receive Cosentyx injections?

Most adults start with weekly injections for the first five weeks, then shift to once every four weeks. Children follow the same schedule, though their dose size depends on body weight.

What changes if someone has a different condition like psoriatic arthritis or ankylosing spondylitis?

The schedule stays the same across plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Only the total amount injected per visit differs by indication and weight.

Can the dosing interval be adjusted or skipped?

Some patients and doctors extend intervals to every six or eight weeks once symptoms are controlled, but this change is made only after discussion with the prescriber. Missing a dose means taking it as soon as remembered and then returning to the original schedule.

When does the patent for Cosentyx expire?

The main U.S. patent protection for secukinumab, the active ingredient in Cosentyx, is expected to end in 2029, opening the door for potential biosimilar competition after that date.

Who makes Cosentyx and are there alternatives?

Novartis manufactures Cosentyx. Competing IL-17 inhibitors include Taltz (ixekizumab) and Siliq (brodalumab), while TNF inhibitors such as Humira and Enbrel remain common alternatives for the same conditions.

DrugPatentWatch.com